Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?

Virpax Pharmaceuticals (NASDAQ:VRPX) stock is rocketing higher on Wednesday after the preclinicalstage pharmaceutical company announced positive results from a swine model pilot study. Virpax Pharmaceuticals has released results from its swine model study of Probudur. This is a treatment candidate to assist in immediate and long-term pain management at wound sites. Virpax Pharmaceuticals is developing Probudur as a replacement for opioids. The swine model study resulted in it injecting four pigs with the tr ...